RAPT Therapeutics Inc (RAPT)
8.11
+0.31
(+3.97%)
USD |
NASDAQ |
Apr 26, 16:00
8.11
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Total Assets (Quarterly): 173.33M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 173.33M |
September 30, 2023 | 199.72M |
June 30, 2023 | 220.76M |
March 31, 2023 | 248.33M |
December 31, 2022 | 266.21M |
September 30, 2022 | 209.49M |
June 30, 2022 | 222.00M |
March 31, 2022 | 187.55M |
December 31, 2021 | 198.64M |
September 30, 2021 | 217.46M |
June 30, 2021 | 231.08M |
Date | Value |
---|---|
March 31, 2021 | 105.92M |
December 31, 2020 | 118.97M |
September 30, 2020 | 128.97M |
June 30, 2020 | 139.68M |
March 31, 2020 | 150.89M |
December 31, 2019 | 84.60M |
September 30, 2019 | 58.37M |
June 30, 2019 | 68.11M |
March 31, 2019 | 67.86M |
December 31, 2018 | 69.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
58.37M
Minimum
Sep 2019
266.21M
Maximum
Dec 2022
170.00M
Average
187.55M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
Emergent BioSolutions Inc | 1.823B |
Avinger Inc | 13.77M |
Tonix Pharmaceuticals Holding Corp | 154.46M |
Skye Bioscience Inc | 11.94M |
Axsome Therapeutics Inc | 588.24M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 26.29M |
Shareholders Equity (Quarterly) | 147.04M |